Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034

人口学 入射(几何) 自回归积分移动平均 医学 中国 队列 相对风险 宫颈癌 死亡率 代群效应 地理 置信区间 癌症 统计 时间序列 外科 内科学 考古 社会学 物理 光学 数学
作者
Shuang Li,Min Huang,Yan Zhu,Hai Zeng,Fan Zhang
出处
期刊:European Journal of Cancer Prevention [Lippincott Williams & Wilkins]
被引量:8
标识
DOI:10.1097/cej.0000000000000849
摘要

Objective This study aimed to analyze long-term trends of cervical cancer (CC) burden in China based on the GBD 2019 data and provide information and data support for formulating corresponding policies to control CC. Methods Incidence and mortality rate data of CC in China were described using GBD 2019 data. The Joinpoint regression analysis and age-period-cohort model were implemented to describe temporal trends of CC in China over the past 30 years. ARIMA model was used to predict trends of disease burden of CC in China for the next 15 years. Results From 1990 to 2019, the relative percentage change in age-standardized incidence rate (ASIR) of CC in Chinese women was 30.91 (95% UI: −50.13 to 96.78), and the relative percentage change in age-standardized mortality rate (ASMR) was −12.37 (95% UI: −63.54 to 28.52). The age-period-cohort model had different impacts on incidence and mortality rates. Overall annual percentage change (APC) (net drift) in incidence risk was 1.22 (95% CI: 0.87–1.57), and the overall APC (net drift) in mortality risk was −0.143 (95% CI: −0.38 to 0.09). The ARIMA model predicted ASIR and ASMR trends of CC for the next 15 years. Conclusion From 1990 to 2019, the overall incidence risk of CC in Chinese has shown an upward trend, with an earlier occurrence in the high-incidence age groups, while mortality risk showed a downward trend. It is anticipated that over the next 15 years, the incidence rate will decrease, while the mortality rate will initially rise before decreasing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様应助月亮不说话采纳,获得10
刚刚
刚刚
JamesPei应助Zhong采纳,获得10
刚刚
愤怒的蚂蚁完成签到,获得积分10
1秒前
耍酷水杯发布了新的文献求助10
1秒前
研友_VZG7GZ应助DDF采纳,获得30
1秒前
sun完成签到,获得积分10
1秒前
aliu发布了新的文献求助30
2秒前
倚栏听风完成签到 ,获得积分10
2秒前
2秒前
wsyyyooooo发布了新的文献求助10
3秒前
爆米花应助可乐小伙子采纳,获得10
4秒前
4秒前
悦耳康发布了新的文献求助10
4秒前
5秒前
6秒前
含蓄白梦发布了新的文献求助20
6秒前
7秒前
7秒前
7秒前
7秒前
7秒前
8秒前
8秒前
lemon 1118完成签到,获得积分10
8秒前
温暖寻雪发布了新的文献求助10
9秒前
毫无意义完成签到 ,获得积分10
9秒前
豌豆发布了新的文献求助10
9秒前
9秒前
Jason3322完成签到,获得积分10
9秒前
自然的新烟完成签到,获得积分10
10秒前
研友_VZG7GZ应助windcreator采纳,获得10
10秒前
NexusExplorer应助Rita采纳,获得10
10秒前
11秒前
t250完成签到,获得积分10
11秒前
鸡鱼蚝发布了新的文献求助10
12秒前
12秒前
13秒前
悦耳笑蓝发布了新的文献求助10
13秒前
包容新蕾完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6063279
求助须知:如何正确求助?哪些是违规求助? 7895702
关于积分的说明 16314347
捐赠科研通 5206687
什么是DOI,文献DOI怎么找? 2785451
邀请新用户注册赠送积分活动 1768055
关于科研通互助平台的介绍 1647487